EGFR and ovarian carcinoma: The over-expression of EGFR was reported to be involved in EMT activation via the Akt/Erk1/2 pathways, inducing Vimentin expression and dowregulation of E-cadherin favoring invasiveness in ovarian cancer cells [20].